BioHarvest Sciences Inc. (BHST)
NASDAQ: BHST · Real-Time Price · USD
5.95
+0.64 (11.98%)
At close: Feb 21, 2025, 4:00 PM
6.30
+0.35 (5.96%)
After-hours: Feb 21, 2025, 7:12 PM EST

Company Description

BioHarvest Sciences Inc. operates as a biotechnology company.

The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells.

The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals.

It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products.

Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes.

The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

BioHarvest Sciences Inc.
Country Canada
Founded 2007
Industry Packaged Foods
Sector Consumer Staples
CEO Ilan Sobel

Contact Details

Address:
1140-625 Howe Street
Vancouver, BC V6C 2T6
Canada
Phone 604 622 1186
Website bioharvest.com

Stock Details

Ticker Symbol BHST
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001723464
ISIN Number CA09076J2074
SIC Code 2834

Key Executives

Name Position
Ilan Sobel Chief Executive Officer
Dr. Zaki Rakib Ph.D. Co-Founder, Executive Chairman and President
Dr. Yochi Hagay Ph.D. Co-Founder, Chief Technology Officer and Member of Scientific Advisory Board
Dr. Ilana Belzer Ph.D. Chief Operating Officer
David K. Ryan Vice President of Investor Relations and Secretary
Dr. Brian S. Cornblatt Chief Medical Officer and Member of Scientific Advisory Board
Bar Dichter Chief Financial Officer
Matthew Joseph Zrebiec Vice President of Business Development

Latest SEC Filings

Date Type Title
Feb 18, 2025 6-K Report of foreign issuer
Feb 14, 2025 6-K Report of foreign issuer
Feb 12, 2025 SCHEDULE 13G Filing
Feb 12, 2025 6-K Report of foreign issuer
Feb 11, 2025 6-K Report of foreign issuer
Jan 23, 2025 6-K Report of foreign issuer
Jan 22, 2025 6-K Report of foreign issuer
Jan 8, 2025 6-K Report of foreign issuer
Dec 11, 2024 6-K Report of foreign issuer
Nov 26, 2024 6-K Report of foreign issuer